| Literature DB >> 17361314 |
N Mittmann1, B C Chan, S Knowles, N H Shear.
Abstract
Intravenous immunoglobulin (IVIG) has been proposed as a treatment for toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS). A number of retrospective and prospective studies have been conducted, with varying levels of evidence for the efficacy of IVIG. Recent publications provide opposing conclusions. A multi-center, comparative, long-term analysis needs to be conducted to determine the role of IVIG in the management of patients with SJS/TEN.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17361314
Source DB: PubMed Journal: Skin Therapy Lett ISSN： 1201-5989